{
  "docId": "019dd923-5f69-752d-a9b6-2758ff8024b8",
  "docSlug": "IOYPUci1JeH6qtF9hngI",
  "documentTitle": "See the 21-slide pitch deck a biotech startup used to convince investors like Pfizer to bet on fixing damaged organs",
  "authorId": "Pitchdecks",
  "authorName": "Agomab Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 17,
  "pageCount": 21,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b6-2758ff8024b8/17",
  "deckHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.94,
        "x": 0.03,
        "y": 0.43
      },
      "kind": "list",
      "text": "Well-characterized profile: Strong efficacy data in wealth of acute and chronic in vivo models; PK and exposure profile in line with use in acute and chronic diseases; Good safety profile GLP tox studies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05060276-ecf0-41f6-aaac-ffc51966f640",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.94,
        "x": 0.03,
        "y": 0.63
      },
      "kind": "list",
      "text": "Development status: Chronic GLP-tox ongoing; Ph1 SAD in healthy volunteers planned for H2'22; Ph2a studies planned for H2'23",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "928cc179-d738-4728-bc92-42b8f7b7521f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.94,
        "x": 0.03,
        "y": 0.23
      },
      "kind": "list",
      "text": "Advantageous drug properties: Potent HGF mimetic antibody, developed on the argenx antibody platform; Triggers potent and selective MET activation, reproducing full HGF biology; Cross-reactive with rodent, NHP and human MET, excellent PK & PD properties",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2de6145-579b-4471-bf44-957af74280db",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.75,
        "x": 0.12,
        "y": 0.05
      },
      "kind": "title",
      "text": "AGMB-101 delivers full HGF pharmacology with potential in array of acute and severe-chronic disorders",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6690fbbd-91a6-4dae-9450-2c861599da3c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}